In addition, they can also be injected in other non-tau Tg models, for example, those that recapitulate other aspects of the disease (e.g., amyloid pathology) or express tauopathy-associated risk gene variants (e.g., TREM2) [113,114]. The gene discussed is MAPT; the disease is amyloidosis.